Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | 0 | - |
| Net profit | -41.36k | 209.49% |
| EBITDA | 0 | 100.00% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €62.27k |
Number of shares | 10.28m |
52-week high/low | €0.0119 - €0.00371 |
| Dividends | No |
Beta | 0.64 |
P/E ratio | 9.40 |
PEG ratio | -0.07 |
P/B ratio | -0.11 |
P/S ratio | 0.00 |
Company profile
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Deliver System, a platform using nanotechnology in the bio delivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. The company was incorporated in 2005 and is headquartered in Vancouver, Canada.
| Name | NanoSphere Health Sciences |
| CEO | Michael Alexander Iverson |
| Headquarters | Vancouver,
bc Canada |
| Website | |
| IPO | 08/10/2009 |
| Employees | 3 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Pnk | NSHSF |
Frankfurt | 2CG.F |
Cnq | NSHS.CN |
Sto | ANNE-B.ST |
Nse | ICIL.NS |
Shh | 605003.SS |
Tlv | ALTF.TA |